(Q35030582)

5 August 2017

1 reference

title

Impact of drotrecogin alfa (activated) on resource use and implications for reimbursement (English)

1 reference

5 August 2017

1 reference

Joseph F Dasta

1

1 reference

5 August 2017

Liesl M Cooper

series ordinal

2

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

22

1 reference

5 August 2017

issue

12 Pt 2

1 reference

5 August 2017

page(s)

216S-222S

1 reference

Efficacy and safety of recombinant human activated protein C for severe sepsis

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.216S.33703

STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.216S.33703

Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.216S.33703

G-CSF for the prophylaxis of neutropenic fever in patients with small cell lung cancer receiving myelosuppressive antineoplastic chemotherapy: meta-analysis and pharmacoeconomic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.216S.33703

Acute renal failure in hospitalized patients: part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.216S.33703

10.1592/PHCO.22.18.216S.33703

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference